Hematopoietic Stem Cell TransplantationTransplantation, HomologousBone MarrowHematopoietic Stem CellsBone Marrow CellsBone Marrow TransplantationGraft vs Host DiseaseFetal BloodTransplantation ConditioningBone and BonesHematologic NeoplasmsStem CellsTransplantation ChimeraHematopoiesisGraft vs Leukemia EffectTissue DonorsWhole-Body IrradiationLeukemiaAntigens, CD34Stem Cell TransplantationSpinal CordMice, Inbred C57BLGraft SurvivalHistocompatibilityBone Marrow DiseasesFlow CytometryTransplantation, AutologousBone RemodelingBusulfanColony-Forming Units AssayCell DifferentiationHistocompatibility TestingGraft vs Tumor EffectTreatment OutcomeBone Marrow ExaminationLeukemia, Myeloid, AcuteChimerismMyelodysplastic SyndromesMyeloablative AgonistsHematologic DiseasesCells, CulturedAllograftsRecurrenceBone Marrow NeoplasmsT-LymphocytesAnemia, AplasticRetrospective StudiesTime FactorsCell LineageVidarabineHematopoietic Stem Cell MobilizationPrecursor Cell Lymphoblastic Leukemia-LymphomaPeripheral Blood Stem Cell TransplantationCord Blood Stem Cell TransplantationBone DensityLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHLA AntigensCell SeparationSpinal Cord InjuriesCytomegalovirus InfectionsAcute DiseaseTransplantation, IsogeneicBone Marrow PurgingRadiation ChimeraLymphocyte TransfusionRemission InductionImmunophenotypingImmunosuppressive AgentsSiblingsBone ResorptionLymphocyte DepletionSurvival AnalysisSurvival RateTransplantation ImmunologyHepatic Veno-Occlusive DiseaseAntigens, CDUmbilical CordLeukemic InfiltrationLeukemia, MyeloidStromal CellsIsoantigensMice, SCIDThymus GlandMice, Inbred BALB CCystitisStem Cell NicheMultiple MyelomaStem Cell FactorCyclophosphamideSpleenMinor Histocompatibility AntigensBone NeoplasmsInfant, NewbornCell ProliferationPrimary MyelofibrosisNeoplasm, ResidualOpportunistic InfectionsSevere Combined ImmunodeficiencyCombined Modality TherapyGranulocyte Colony-Stimulating Factor